Bis(4-chlorobenzoyl) peroxide
Common Name: | Bis(4-chlorobenzoyl) peroxide |
IUPAC Name: | (4-chlorobenzoyl) 4-chlorobenzenecarboperoxoate |
Molecular Formula: | C14H8Cl2O4 |
SMILES: | C1=CC(=CC=C1C(=O)OOC(=O)C2=CC=C(C=C2)Cl)Cl |
Inchi: | 1S/C14H8Cl2O4/c15-11-5-1-9(2-6-11)13(17)19-20-14(18)10-3-7-12(16)8-4-10/h1-8H |
Inchi Key: | OXYKVVLTXXXVRT-UHFFFAOYSA-N |
Cas No: | 94-17-7 |
Name | Value |
Lipinski Violations | 1 |
Ghose Violations | 0 |
Veber Violations | 0 |
Egan Violations | 0 |
Muegge Violations | 0 |
---|
Name | Value |
Molecular Weight (g/mol) | 311.12 |
Mass (g/mol) | 309.98 |
Molar Refractivity | 73.73 |
Net Charge | |
HBD | |
HBA | 4 |
Rt Bonds | 5 |
Rings | 2 |
TPSA | 52.60 |
Hetero Atoms | 6 |
Heavy Atoms | 20 |
Aromatic Heavy Atoms | 12 |
Melting Point (°C) | 137-138 |
Boiling Point (°C@760.00mm Hg) | |
Vapor Pressure (mmHg@25.00 °C) | |
Vapor Density (Air =1) | |
Fraction Csp3 | 0.00 |
LogP | 3.922 |
iLOGP | 3.12 |
XLOGP3 | 4.72 |
WLOGP | 3.92 |
MLOGP | 4.54 |
ESOL Log S | -4.86 |
ESOL Solubility (mg/ml) | 0.004 |
ESOL Solubility (mol/l) | 0 |
ESOL Class: esol_class | Moderately soluble |
Ali Log S | -5.55 |
Ali Solubility (mg/ml) | 0 |
Ali Solubility (mol/l) | 0 |
Ali Class | Moderately soluble |
Silicos-IT LogSw | -5.51 |
Silicos-IT Solubility (mg/ml) | 0 |
Silicos-IT Solubility (mol/l) | 0 |
Silicos-IT Class | Moderately soluble |
---|
Name | Value |
GI Absorption | High |
BBB Permeable | 1 |
PgP Substrate | 0 |
Log Kp (cm/s) | -4.85 |
Bioavailability Score | 0.55 |
Caco2 | 1 |
Human Intestinal Absorption | 1 |
Plasm Protein Binding | 1.021 |
CYP1A2 Inhibitor | 1 |
CYP2C19 Inhibitor | 1 |
CYP2C9 Inhibitor | 1 |
CYP2D6 inhibitor | 0 |
CYP3A4 inhibitor | 0 |
Ames mutagenesis | 0 |
Acute Oral Toxicity | 2.194 |
Carcinogenicity (Binary) | 0 |
Carcinogenicity (Trinary) | Non-required |
Eye Irritation | 1 |
Hepatotoxicity | 1 |
Androgen Receptor Binding | 0 |
Aromatase Binding | 1 |
Estrogen Receptor Binding | 0 |
Glucocorticoid Receptor Binding | 0 |
Thyroid Receptor Binding | 0 |
BRCP inhibitor | 0 |
BSEP inhibitor | 1 |
OATP1B1 inhibitor | 1 |
OATP1B3 inhibitor | 1 |
OATP2B1 inhibitor | 0 |
OCT1 inhibitor | 0 |
OCT2 inhibitor | 0 |
---|